Strategies for optimizing targeting and delivery of mucosal HIV vaccines

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Immunology

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.200939269PMID 19609978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Letters to the Editor Letters to the Editor Comment on "Trafficking of Antigen-Specific CD8 T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination"

  2009cited by this paper
• Memory CD8 T-cell compartment grows in size with immunological experience

  2009cited by this paper
• Response to Comment on “Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination”

  2009cited by this paper
• Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge

  2009cited by this paper
• Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection

  2009cited by this paper
• Faculty Opinions recommendation of Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

  2009cited by this paper
• Special regulatory T‐cell review: FOXP3 biochemistry in regulatory T cells – how diverse signals regulate suppression

  2008cited by this paper
• Engineered Expression of the TLR5 Ligand Flagellin Enhances Paramyxovirus Activation of Human Dendritic Cell Function

  2008cited by this paper
• Virus-sized vaccine delivery systems.

  2008cited by this paper
• Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

  2008cited by this paper
• Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope

  2008cited by this paper
• Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

  2008cited by this paper
• Sublingual vaccination with influenza virus protects mice against lethal viral infection

  2008cited by this paper
• Vaccine adjuvants alter TCR-based selection thresholds.

  2008cited by this paper
• Mucosally Delivered Dendritic Cells Activate T Cells Independently of IL-12 and Endogenous APCs1

  2008cited by this paper
• Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

  2008cited by this paper
• Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

  2008cited by this paper
• No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation1

  2008cited by this paper
• CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.

  2008cited by this paper
• Lipid A and liposomes containing lipid A as antigens and adjuvants.

  2008cited by this paper
• Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5

  2008cited by this paper
• Human monocytes/macrophages are a target of Neisseria meningitidis Adhesin A (NadA)

  2008cited by this paper
• TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines.

  2008cited by this paper
• Tentative T Cells: Memory Cells Are Quick to Respond, but Slow to Divide

  2008cited by this paper
• Molecular and cellular signatures of human vaccine adjuvants

  2008cited by this paper
• Mast cell activators: a new class of highly effective vaccine adjuvants

  2008cited by this paper
• Nonmucosal Alphavirus Vaccination Stimulates a Mucosal Inductive Environment in the Peripheral Draining Lymph Node1

  2008cited by this paper
• Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.

  2008cited by this paper
• Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

  2008cited by this paper
• Combination dual responsive polypeptide vectors for enhanced gene delivery.

  2008cited by this paper
• Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.

  2008cited by this paper
• Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31

  2008cited by this paper
• Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.

  2008cited by this paper
• Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

  2008cited by this paper
• Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

  2008cited by this paper
• Novel Vaccination Protocol with Two Live Mucosal Vectors Elicits Strong Cell-Mediated Immunity in the Vagina and Protects against Vaginal Virus Challenge1

  2008cited by this paper
• Development of small, homogeneous pDNA particles condensed with mono-cationic detergents and encapsulated in a multifunctional envelope-type nano device.

  2008cited by this paper
• Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination1

  2008cited by this paper
• Generation of gut‐homing T cells and their localization to the small intestinal mucosa

  2007cited by this paper
• Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.

  2007cited by this paper
• Cutting Edge: Peyer’s Patch Plasmacytoid Dendritic Cells (pDCs) Produce Low Levels of Type I Interferons: Possible Role for IL-10, TGFβ, and Prostaglandin E2 in Conditioning a Unique Mucosal pDC Phenotype1

  2007cited by this paper
• Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.

  2007cited by this paper
• Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses

  2007cited by this paper
• The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

  2007cited by this paper
• IFN-γ and R-848 Dependent Activation of Human Monocyte-Derived Dendritic Cells by Neisseria meningitidis Adhesin A1

  2007cited by this paper
• Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

  2007cited by this paper
• A novel M cell–specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

  2007cited by this paper
• Activation phenotype, rather than central– or effector–memory phenotype, predicts the recall efficacy of memory CD8+ T cells

  2007cited by this paper
• A Novel Functional CTL Avidity/Activity Compartmentalization to the Site of Mucosal Immunization Contributes to Protection of Macaques against Simian/Human Immunodeficiency Viral Depletion of Mucosal CD4+ T Cells

  2007cited by this paper
• Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).

  2007cited by this paper
• The Context of Epitope Presentation Can Influence Functional Quality of Recalled Influenza A Virus-Specific Memory CD8+ T Cells1

  2007cited by this paper
• TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus.

  2007cited by this paper
• Comparison of intranasal with targeted lymph node immunization using PR8‐Flu ISCOM adjuvanted HIV antigens in macaques

  2007cited by this paper
• Mucosal HIV-1 Pox Virus Prime-Boost Immunization Induces High-Avidity CD8+ T Cells with Regime-Dependent Cytokine/Granzyme B Profiles1

  2007cited by this paper
• Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.

  2007cited by this paper
• Cutting Edge: Migration to Nonlymphoid Tissues Results in Functional Conversion of Central to Effector Memory CD8 T Cells1

  2007cited by this paper
• Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

  2007cited by this paper
• Mucosal dendritic cells.

  2007cited by this paper
• Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization1

  2007cited by this paper
• Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles.

  2007cited by this paper
• Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.

  2006cited by this paper
• Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

  2006cited by this paper
• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

  2006cited by this paper
• 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin.

  2006cited by this paper
• In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

  2006cited by this paper
• Rapid Virus Dissemination in Infant Macaques after Oral Simian Immunodeficiency Virus Exposure in the Presence of Local Innate Immune Responses

  2006cited by this paper
• Virus-like particles: Passport to immune recognition

  2006cited by this paper
• Mucosal vaccines: the promise and the challenge

  2006cited by this paper
• Cutting Edge: Gut Microenvironment Promotes Differentiation of a Unique Memory CD8 T Cell Population

  2006cited by this paper
• Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A.

  2006cited by this paper
• Dynamic Programing of CD8+ T Cell Trafficking after Live Viral Immunization

  2006cited by this paper
• Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.

  2006cited by this paper
• Enhancement of CD8+ T Cell Immunity in the Lung by CpG Oligodeoxynucleotides Increases Protective Efficacy of a Modified Vaccinia Ankara Vaccine against Lethal Poxvirus Infection Even in a CD4-Deficient Host

  2006cited by this paper
• The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node.

  2005cited by this paper
• Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.

  2005cited by this paper
• Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues

  2005cited by this paper
• Effective nasal influenza vaccine delivery using chitosan.

  2005cited by this paper
• Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan

  2005cited by this paper
• Functional specialization of gut CD103 dendritic cells in the regulation of tissue-selective T cell homing

  2005cited by this paper
• The low‐toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells

  2005cited by this paper
• In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles.

  2005cited by this paper
• CD8+ T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligodeoxynucleotides

  2005cited by this paper
• Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.

  2005cited by this paper
• Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells.

  2005cited by this paper
• Isolated Lymphoid Follicles Can Function as Sites for Induction of Mucosal Immune Responses

  2004cited by this paper
• Mucosal AIDS vaccines: current status and future directions

  2004cited by this paper
• Rapid Development of T Cell Memory1

  2004cited by this paper
• Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract

  2004cited by this paper
• A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.

  2004cited by this paper
• Progress on new vaccine strategies against chronic viral infections.

  2004cited by this paper
• Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.

  2004cited by this paper
• Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A.

  2004cited by this paper
• Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.

  2004cited by this paper
• Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

  2004cited by this paper
• The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues1

  2004cited by this paper
• Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia.

  2004cited by this paper
• CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

  2004cited by this paper
• Retinoic acid imprints gut-homing specificity on T cells.

  2004cited by this paper
• Recombinant Modified Vaccinia Virus Ankara Administration and Boosting with a Bacille Calmette-Guérin Vaccine Using Mucosal of Mycobacterium tuberculosis Efficacy Against Enhanced Immunogenicity and Protective

  2003cited by this paper
• Immunostimulant Patch Containing Heat-Labile Enterotoxin from Escherichia coli Enhances Immune Responses to Injected Influenza Virus Vaccine through Activation of Skin Dendritic Cells

  2003cited by this paper

• Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.

  2018cites this paper
• Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs

  2015cites this paper
• "Oral Vaccine Antigen Induced Immune Response Signalling Pathways: Current and Future Perspectives"

  2014cites this paper
• All eyes on the next generation of HIV vaccines: strategies for inducing a broadly neutralizing antibody response.

  2014cites this paper
• Novel approaches in polyepitope T-cell vaccine development against HIV-1

  2014cites this paper
• Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8+ T-cell avidity and protective immunity

  2013cites this paper
• [Innate and adaptative immunity of the female genital tract].

  2012cites this paper
• Immunité innée et adaptative du tractus génital féminin

  2012cites this paper
• Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.

  2012cites this paper
• This information is current as Activation Does Not Correlate with Better T Cell Dendritic Cells : Enhanced Viral Capture HIV-1 Capture and Antigen Presentation by Moris and

  2012cites this paper
• Unpolarized Release of Vaccinia Virus and HIV Antigen by Colchicine Treatment Enhances Intranasal HIV Antigen Expression and Mucosal Humoral Responses

  2011cites this paper
• CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution

  2011cites this paper
• Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant

  2011cites this paper
• Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia.

  2011cites this paper
• The role of the lymphatic system in vaccine trafficking and immune response.

  2011cites this paper
• HIV‐1: From escapism to conservatism

  2011cites this paper
• Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.

  2011cites this paper
• Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.

  2011cites this paper
• Lack of IL‐7 and IL‐15 signaling affects interferon‐γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells

  2011cites this paper
• Lympho-geographical concepts in vaccine delivery.

  2010cites this paper
• Molecular pathways regulating CD4(+) T cell differentiation, anergy and memory with implications for vaccines.

  2010cites this paper
• Current progress in the development of a prophylactic vaccine for HIV-1

  2010influential citation
• Role of adjuvants in modeling the immune response

  2010cites this paper
• Memories that last forever: strategies for optimizing vaccine T-cell memory.

  2010cites this paper
• Mucosal adjuvants.

  2010cites this paper
• CHARACTERIZATION OF ALPHA-GALACTOSYLCERAMIDE AS A MUCOSAL ADJUVANT

  2010influential citation
• What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

  2009cites this paper
• Current World Literature

  2006cites this paper